Drug Type Oligonucleotide |
Synonyms- |
Action modulators |
Mechanism Complement system proteins modulators(Complement system proteins modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glomerulonephritis, IGA | Discovery | United Kingdom | 02 Sep 2025 | |
| Glomerulonephritis, IGA | Discovery | United Kingdom | 02 Sep 2025 |





